4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-21-012676
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Baxter Jeff · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-17 | Grant or award : show line 1 in the form Stock Options (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X03/wf-form4_162439725270272.xml…